Close Menu

This year may have been the CRISPR's breakout year as a technology, but the patent dispute over who owns the intellectual property for the tool is only getting underway. According to Jacob Sherkow at Stanford's Law and Biosciences Blog, a patent examiner has issued an Initial Interference Memo, paving the way for an interference proceeding.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.